Complete Histological Response to Neoadjuvant Pembrolizumab in High-Risk Stage IIC Melanoma of the Nasal Ala: A Case Report – Supplemental Material

Published: 18 August 2026| Version 1 | DOI: 10.17632/nvt5wsgswy.1
Contributor:
Emma Clochard

Description

Supplementary material associated with the case report “Complete Histological Response to Neoadjuvant Pembrolizumab in High-Risk Stage IIC Melanoma of the Nasal Ala: A Case Report.

Files

Categories

Dermatology

Licence